Allegheny Financial Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,366
Closed -$255K 254
2024
Q3
$255K Buy
2,366
+1
+0% +$109 0.06% 213
2024
Q2
$257K Buy
2,365
+2
+0.1% +$236 0.07% 188
2024
Q1
$312K Sell
2,363
-27
-1% -$3.37K 0.1% 161
2023
Q4
$291K Buy
2,390
+194
+9% +$21.6K 0.09% 167
2023
Q3
$246K Hold
2,196
0.09% 162
2023
Q2
$320K Buy
2,196
+1
+0% +$136 0.15% 118
2023
Q1
$284K Hold
2,195
0.11% 134
2022
Q4
$280K Buy
2,195
+2
+0.1% +$232 0.12% 132
2022
Q3
$229K Hold
2,193
0.11% 135
2022
Q2
$230K Buy
2,193
+1
+0% +$119 0.11% 134
2022
Q1
$280K Sell
2,192
-66
-3% -$7.96K 0.12% 122
2021
Q4
$278K Buy
2,258
+1
+0% +$131 0.11% 124
2021
Q3
$321K Hold
2,257
0.15% 103
2021
Q2
$352K Buy
+2,257
New +$366K 0.16% 93
2021
Q1
Sell
-2,423
Closed -$362K 139
2020
Q4
$362K Buy
+2,423
New +$342K 0.19% 75

Other funds holding ZBH

Allegheny Financial Group's ZBH Position: Q4 2024 in Review

Allegheny Financial Group sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 2,366 shares — an estimated $255K sold.

Allegheny Financial Group first reported a position in ZBH in Q4 2020 and held it in 15 quarters. The position peaked at $362K in Q4 2020. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Allegheny Financial Group reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Allegheny Financial Group sold 2,366 Zimmer Biomet shares in Q4 2024, an estimated $255K.
  • Allegheny Financial Group first reported a position in Zimmer Biomet in Q4 2020 and held it in 15 quarters.
  • Allegheny Financial Group's Zimmer Biomet position peaked at $362K in Q4 2020.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Allegheny Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.